COMMUNIQUÉS West-GlobeNewswire

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
11/04/2026
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated patients with HER2-expressing, recurrent endometrial cancer [...]
NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification
11/04/2026
A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement — covering botanical formula composition, ingredient-level research, dosage disclosure, 60-day refund policy, and the consumer [...]
Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas
11/04/2026
Join the Grand Opening Celebration on May 1, 2026, for an Evening of Beauty and Innovation Lubbock, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa , a leader in aesthetic and [...]
Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency
11/04/2026
A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, product variety, and publicly visible brand information across the Gentle Patches pill-free [...]
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
10/04/2026
SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
10/04/2026
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s CFO, Jack Glenn, will [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/04/2026
CAMBRIDGE, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/04/2026
BRISBANE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on April 8, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera [...]
Pelthos Therapeutics Announces CFO Transition
10/04/2026
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company [...]
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
10/04/2026
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are living with DMD in the U.S. NEW YORK, April 10, 2026 (GLOBE NEWSWIRE [...]
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
10/04/2026
WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the [...]
IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information
11/04/2026
New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide access, three-entity telehealth structure, and key considerations for prospective patients [...]
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
10/04/2026
WALTHAM, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility
10/04/2026
New 2026 Program Overview Details Compounded NAD+ Therapy Access, Three-Entity Telehealth Structure, and What Patients Should Know Before Starting Clinician-Reviewed Prescription NAD+ Programs Cheyenne, WY, April 10, [...]
Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System
10/04/2026
Bay Alarm Medical Recognized for Excellence in Safety and Innovation by Medical Daily Concord, CALIFORNIA, April 10, 2026 (GLOBE NEWSWIRE) -- Bay Alarm Medical, a leader in personal emergency response systems, has been [...]
Checkerspot Introduces Algolein™, a New Line of Specialized Lipids from Microalgae for Personal Care and Cosmetics
10/04/2026
Algolein™ debuts with a high-oleic algal oil under the name Algolein™ TG C18/80 designed without genetic modification using microalgae fermentation to deliver targeted performance, consistency, and sustainability [...]
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
10/04/2026
Collaboration marks the first clinical pilot of AI-assisted MRI analysis for endometriosis. Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai, a healthcare technology company developing artificial [...]
Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering
10/04/2026
OCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
10/04/2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Pages